References:
  1. Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev. 1996 Oct;9(4):563-84. doi: 10.1128/CMR.9.4.563. PMID: 8894352; PMCID: PMC172910.
  2. CDC - dpdx - blastocystis hominis. Centers for Disease Control and Prevention. October 21, 2019. Accessed June 24, 2024. https://www.cdc.gov/dpdx/blastocystis/index.html.
  3. Ustün S, Turgay N. Blastocystis hominis ve bağirsak hastaliklari [Blastocystis hominis and bowel diseases]. Turkiye Parazitol Derg. 2006;30(1):72-6. Turkish. PMID: 17106862.
  4. Mayneris-Perxachs, J., Arnoriaga-Rodríguez, M., Garre-Olmo, J., Puig, J., Ramos, R., Trelis, M., Burokas, A., Coll, C., Zapata-Tona, C., Pedraza, S., Pérez-Brocal, V., Ramió, L., Ricart, W., Moya, A., Jové, M., Sol, J., Portero-Otin, M., Pamplona, R., Maldonado, R., & Fernández-Real, J. M. (2022). Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function. The ISME journal16 (9), 2181–2197. https://doi.org/10.1038/s41396-022-01262-3’
  5. Tan K. S. (2008). New insights on classification, identification, and clinical relevance of Blastocystis spp. Clinical microbiology reviews21 (4), 639–665. https://doi.org/10.1128/CMR.00022-08
  6. Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS biology14 (8), e1002533. https://doi.org/10.1371/journal.pbio.1002533
  7. Nishiwaki, H., Ito, M., Ishida, T., Hamaguchi, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H., Kurokawa, K., Katsuno, M., Hirayama, M., & Ohno, K. (2020). Meta-Analysis of Gut Dysbiosis in Parkinson’s Disease. Movement disorders : official journal of the Movement Disorder Society35 (9), 1626–1635. https://doi.org/10.1002/mds.28119
  8. Chaoul, V., Dib, E. Y., Bedran, J., Khoury, C., Shmoury, O., Harb, F., & Soueid, J. (2023). Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease. International journal of molecular sciences24 (19), 14898. https://doi.org/10.3390/ijms241914898
  9. Berthouzoz, E., Lazarevic, V., Zekeridou, A., Castro, M., Debove, I., Aybek, S., Schrenzel, J., Burkhard, P. R., & Fleury, V. (2023). Oral and intestinal dysbiosis in Parkinson’s disease. Revue neurologique179 (9), 937–946. https://doi.org/10.1016/j.neurol.2022.12.010
  10. Scanlan, P. D., Stensvold, C. R., Rajilić-Stojanović, M., Heilig, H. G., De Vos, W. M., O’Toole, P. W., & Cotter, P. D. (2014). The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS microbiology ecology90 (1), 326–330. https://doi.org/10.1111/1574-6941.12396
  11. Beghini, F., Pasolli, E., Truong, T. D., Putignani, L., Cacciò, S. M., & Segata, N. (2017). Large-scale comparative metagenomics of Blastocystis, a common member of the human gut microbiome. The ISME journal11 (12), 2848–2863. https://doi.org/10.1038/ismej.2017.139
  12. Nourrisson, C., Scanzi, J., Pereira, B., NkoudMongo, C., Wawrzyniak, I., Cian, A., Viscogliosi, E., Livrelli, V., Delbac, F., Dapoigny, M., & Poirier, P. (2014). Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PloS one9 (11), e111868. https://doi.org/10.1371/journal.pone.0111868
  13. Yason, J. A., Liang, Y. R., Png, C. W., Zhang, Y., & Tan, K. S. W. (2019). Interactions between a pathogenic Blastocystis subtype and gut microbiota: in vitro and in vivo studies. Microbiome7 (1), 30. https://doi.org/10.1186/s40168-019-0644-3